• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume7, Issue8

UVEITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

    Nugraha Wahyu Cahyana

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 5380-5386

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

SLE or Systemic Lupus Erythematosus is known as an autoimmune disease, usually affect multiple systems include the eyes organ. We report a 26-year-old female, complained about painless blurred vision in the right eye since 6 months ago. The examination result shown no history of low-grade fever, fatigue, photosensitivity, arthralgia, and hair loss, erythema over the cheeks, neck, hands, chest, and back. The  visual acuity examination of the right eye was 1/300, keratic precipitates and band keratopathy were not found while posterior synechiae were found. Visual acuity of left eyes was 6/40 and was found normal from anterior to the posterior’s segment. Ultrasonography (USG) test showed severe OD. Severe Vitreous Opacity (suspect chronic inflammatory), but retina in its place. A serological test revealed positive PCNA with 25 intensity, negative RF, and negative ANA IFA results. The patient was consulted to the internal medicine department and was diagnosed with systemic SLE  with ocular involvement. For eight weeks Oral corticosteroid was given. Six weeks after treatment, the opacity of the vitreous had decreased and the visual acuity of the right eye has improved. A case of uveitis in SLE disease can be treated with corticosteroid therapy. Management needs to be holistic, both systemic and ocular. SLE systemic management generally improves ophthalmological outcome.
Keywords:
  • PDF (257 K)
  • XML
(2021). UVEITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). European Journal of Molecular & Clinical Medicine, 7(8), 5380-5386.
Nugraha Wahyu Cahyana. "UVEITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)". European Journal of Molecular & Clinical Medicine, 7, 8, 2021, 5380-5386.
(2021). 'UVEITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)', European Journal of Molecular & Clinical Medicine, 7(8), pp. 5380-5386.
UVEITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). European Journal of Molecular & Clinical Medicine, 2021; 7(8): 5380-5386.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 13
  • PDF Download: 28
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus